CTM executive-director files Form 4 for $1.15 share sales
Rhea-AI Filing Summary
Castellum, Inc. (CTM) reported insider share sales by a senior executive and director. The reporting person, who serves as General Counsel, Secretary and EVP - Strategy and is also a director and other related person, filed a Form 4 as an individual filer. On 11/14/2025, they sold 90,000 shares of common stock at $1.15 per share, and on 11/17/2025 they sold an additional 10,000 shares at $1.156 per share, both coded as open-market sales (transaction code "S").
After these transactions, the reporting person beneficially owned 7,423,973 shares of Castellum common stock in direct form. The form includes a checkbox to indicate that a transaction was made pursuant to a Rule 10b5-1(c) trading plan intended to satisfy affirmative defense conditions, though no additional explanatory remarks are provided.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Castellum, Inc. (CTM) report on this Form 4?
The Form 4 reports that a Castellum insider sold 90,000 shares of common stock on 11/14/2025 at $1.15 per share and 10,000 shares on 11/17/2025 at $1.156 per share, both classified as open-market sales (code "S").
Who is the reporting person in the Castellum (CTM) Form 4 and what is their role?
The reporting person is identified as a Director, Officer, and Other related person of Castellum. Their officer titles are General Counsel, Secretary, and EVP - Strategy.
How many Castellum (CTM) shares does the insider own after the reported sales?
Following the reported transactions, the insider beneficially owns 7,423,973 shares of Castellum common stock, held in direct ownership form.
Were any derivative securities reported in this Castellum (CTM) Form 4?
No derivative securities, such as options, warrants, or convertible instruments, are listed as acquired, disposed of, or beneficially owned in Table II of this Form 4.
What was the earliest transaction date reported on this Castellum (CTM) Form 4?
The earliest transaction date reported is 11/14/2025, which aligns with the first sale of 90,000 shares of Castellum common stock.
Is there an indication of a Rule 10b5-1 trading plan on this Castellum Form 4?
The form includes a checkbox to indicate if a transaction was made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan intended to satisfy the rule’s affirmative defense conditions, though no additional remarks are provided in the excerpt.
Is this Castellum (CTM) Form 4 filed by one or multiple reporting persons?
The filing indicates that it is a Form filed by One Reporting Person, not a joint or group filing.